F10 and atrial fibrillation: The ENGAGE AF-TIMI 48 (Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis In Myocardial Infarction 48) trial found that the risk of stroke and bleeding increased with increased frailty severity.29